cas 1948273-03-7|| where to buy (2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride

Product Name:(2S,4R)-1-((S)-2-amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride

IUPAC Name:(2S,4R)-1-[(2S)-2-amino-3,3-dimethylbutanoyl]-4-hydroxy-N-[(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl]pyrrolidine-2-carboxamide hydrochloride

: CAS：1948273-03-7; Molecular Formula：C23H33ClN4O3S; Purity：95%+

: Catalog Number：CM362099; Molecular Weight：481.05

Packing Unit	Available Stock	Price($)
CM362099-250mg	in stock	ƴŸ
CM362099-1g	in stock	ǆŪȅ
CM362099-5g	in stock	ȅȅǆ
CM362099-25g	in stock	Ÿƚǆƴ

Inquiry: sales@chemenu.com

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1948273-03-7 regularly via the above email.

Additional Notes

Verification code*

refresh

Product Details

: CAS NO:1948273-03-7; Molecular Formula:C23H33ClN4O3S; Melting Point:-; Smiles Code:O=C([C@H]1N(C([C@@H](N)C(C)(C)C)=O)C[C@H](O)C1)N[C@H](C2=CC=C(C3=C(C)N=CS3)C=C2)C.[H]Cl; Density:

: Catalog Number:CM362099; Molecular Weight:481.05; Boiling Point:; MDL No:; Storage:

Category Infos

: Thiazoles; Thiazoles are very important functional groups in medicinal chemistry. They act as ligands on a variety of biological matrices. Thiazoles are used in a wide range of therapeutic applications, such as antibacterial, antiretroviral, antifungal, antiallergic, antihypertensive, pain treatment, and to control symptoms of schizophrenia.

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

Column Infos

: KT-333; Kymera shared new clinical data from its ongoing KT-333 Phase 1 trial. KT-333, a first-in-class, potent, highly selective, heterobifunctional small molecule degrader of STAT3, demonstrated antitumor responses in hematological malignancies with high unmet need, including relapsed/refractory classic Hodgkin’s lymphoma (cHL), cutaneous T-cell lymphoma (CTCL), and NK-cell lymphoma, at doses that were well-tolerated.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Inquiry Form

Product Details

Category Infos

Column Infos

Related Products